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he core 1 
 
 
 
1-3-galactosyltransferase (T-synthase)
transfers Gal from UDP-Gal to GalNAc
 
 
 
1-Ser/Thr
(Tn antigen) to form the core 1 O-glycan Gal
 
 
 
1-
3GalNAc
 
 
 
1-Ser/Thr (T antigen). The T antigen is a precursor
for extended and branched O-glycans of largely unknown
function. We found that wild-type mice expressed the
 
NeuAc
 
 
 
2-3Gal
 
 
 
1-3GalNAc
 
 
 
1-Ser/Thr primarily in en-
dothelial, hematopoietic, and epithelial cells during devel-
opment. Gene-targeted mice lacking T-synthase instead
T
 
expressed the nonsialylated Tn antigen in these cells and
developed brain hemorrhage that was uniformly fatal by
embryonic day 14. T-synthase–deﬁcient brains formed a
chaotic microvascular network with distorted capillary
lumens and defective association of endothelial cells with
pericytes and extracellular matrix. These data reveal an
unexpected requirement for core 1–derived O-glycans
during angiogenesis.
 
Introduction
 
O-glycans containing GalNAc in 
 
 
 
1 linkage to serines or
threonines occur on many membrane and secreted proteins,
particularly on mucins (Van den Steen et al., 1998). These
types of O-glycans have a limited number of core structures.
The most common structure is the core 1 disaccharide,
which is also the precursor for the branched core 2 trisaccharide
(Fig. 1 A). Both core 1 and core 2 structures can be further
extended and modified into a diverse array of O-glycans of
mostly unknown function. Some complex core 2 and extended
core 1 O-glycans are components of mucin glycoprotein
ligands for the selectins, which initiate leukocyte adhesion to
vascular surfaces during infection, tissue injury, and immune
surveillance (Fukuda, 2002; McEver, 2002; Van Zante and
Rosen, 2003). Other core 1 or core 2 O-glycans may limit
cell adhesion or modulate T cell function (Daniels et al.,
2001; Moody et al., 2001, 2003; Fukuda, 2002).
The enzyme core 1 
 
 
 
1-3-galactosyltransferase (T-synthase)
transfers Gal from UDP-Gal to GalNAc
 
 
 
1-Ser/Thr (Tn
antigen) to form the core 1 O-glycan, Gal
 
 
 
1-3GalNAc
 
 
 
1-
Ser/Thr (T antigen; Ju et al., 2002a,b). Many carcinomas
express the unsubstituted T or Tn antigens (Brockhausen,
1999), and pathological exposure of the Tn antigen on cell
surface or secreted proteins may cause autoimmune disease
(Berger, 1999). Biochemical evidence and database searches
suggest that a single gene, here termed 
 
T-syn
 
, encodes all
T-synthase activity (Ju et al., 2002a,b). Although it was
proposed that another gene encodes a second T-synthase
(Kudo et al., 2002), this gene actually encodes the chaperone
protein Cosmc, which is required for folding and activity of
the 
 
T-syn
 
–encoded T-synthase (Ju and Cummings, 2002).
To reveal the functions of core 1–derived O-glycans in vivo,
we disrupted 
 
T-syn
 
 in mice.
 
Results
 
Disruption of 
 
T-syn
 
 causes fatal embryonic hemorrhage
 
Cre/loxP-mediated gene targeting was used to delete 
 
T-syn
 
(Fig. 1, B–D). 
 
T-syn
 
 
 
/
 
 
 
 mice developed normally. Matings
between 
 
T-syn
 
 
 
/
 
 
 
 mice generated 364 viable progeny, of
which 175 (48%) were male and 189 (52%) were female.
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Genotyping identified 136 (37%) 
 
T-syn
 
 
 
/
 
 
 
 progeny and 228
(63%) 
 
T-syn
 
 
 
/
 
 
 
 progeny but did not identify 
 
T-syn
 
 
 
/
 
 
 
 prog-
eny. To determine whether deletion of 
 
T-syn
 
 on both alleles
caused embryonic lethality, we analyzed 293 embryos at em-
bryonic days 9–16 (E9–16) from timed matings of 
 
T-syn
 
 
 
/
 
 
 
mice. Genotyping revealed 78 (27%) 
 
T-syn
 
 
 
/
 
 
 
, 142 (48%)
 
T-syn
 
 
 
/
 
 
 
, and 73 (25%) 
 
T-syn
 
 
 
/
 
 
 
 progeny (Fig. 1 E). T-synthase
activity in tissue extracts was reduced 
 
 
 
50% in E12 
 
T-syn
 
 
 
/
 
 
 
embryos and was eliminated in 
 
T-syn
 
 
 
/
 
 
 
 embryos, whereas
the activity of 
 
 
 
1-4-galactosyltransferase, which transfers Gal
from UDP-Gal to GlcNAc
 
 
 
1-R, was similar in embryos of all
genotypes (Fig. 1 F). This result confirms that 
 
T-syn
 
 encodes
all T-synthase activity, at least through this stage of develop-
ment. This distinguishes 
 
T-syn
 
 from typical multigene fami-
lies of glycosyltransferases that encode several enzymes with
related structures and functions (Lowe and Marth, 2003).
At E9 
 
T-syn
 
 
 
/
 
 
 
 embryos appeared developmentally nor-
mal but thereafter, they developed progressively larger hem-
orrhages in the brain and spinal cord, with secondary bleed-
ing into the ventricles and spinal canal (Fig. 2). Anemia was
 
frequent, but only after bleeding occurred, and was associ-
ated with growth retardation but not with obvious defects in
organogenesis. Histological examination revealed no placen-
tal abnormalities (unpublished data). Embryonic hemor-
rhage invariably preceded death, supporting a casual rela-
tionship. All 
 
T-syn
 
 
 
/
 
 
 
 embryos died by E14, virtually always
at E13 or E14.
 
T-syn
 
 
 
/
 
 
 
 embryos express the Tn antigen 
but not the T antigen
 
To determine whether the levels of T-synthase activity af-
fected core 1 O-glycosylation in vivo, we probed blots of
embryonic extracts with 
 
Arachis hypogaea
 
 agglutinin (PNA),
a lectin that recognizes the nonsialylated T antigen, and with
 
Helix pomatia
 
 agglutinin (HPA), a lectin that recognizes the
nonsialylated Tn antigen (Fig. 3 A). PNA bound to many
glycoproteins from 
 
T-syn
 
 
 
/
 
 
 
 and 
 
T-syn
 
 
 
/
 
 
 
 embryos but not
from 
 
T-syn
 
 
 
/
 
 
 
 embryos. HPA bound to many glycoproteins
from 
 
T-syn
 
 
 
/
 
 
 
 embryos but exhibited little or no binding to
glycoproteins from 
 
T-syn
 
 
 
/
 
 
 
 and 
 
T-syn
 
 
 
/
 
 
 
 embryos. En-
zymatic desialylation of glycoproteins from 
 
T-syn
 
 
 
/
 
 
 
 and
 
T-syn
 
 
 
/
 
 
 
 embryos was required to expose binding sites for
PNA, indicating that sialic acid capped most core 1 O-gly-
cans to form the NeuAc
 
 
 
2-3Gal
 
 
 
1-3GalNAc
 
 
 
1-Ser/Thr
(sialyl-T antigen; Fig. 1 A). In contrast, desialylation of gly-
coproteins from 
 
T-syn
 
 
 
/
 
 
 
 embryos was not required to ex-
pose binding sites for HPA, suggesting that sialic acid did
not cap most of the Tn antigen to form the NeuAc
 
 
 
2-
6GalNAc
 
 
 
1-Ser/Thr (sialyl-Tn antigen; Fig. 1 A).
To determine which cells expressed core 1 O-glycans in
vivo, we probed embryonic tissue sections with mAbs to the
T antigen, Tn antigen, or sialyl-Tn antigen. Anti-T stained
endothelial, hematopoietic, and epithelial cells in tissues of
 
T-syn
 
 
 
/
 
 
 
 embryos, but only after enzymatic desialylation of
the tissue sections (Fig. 3, C and D, and not depicted). In
contrast, anti-Tn stained endothelial, hematopoietic, and
epithelial cells in tissues of 
 
T-syn
 
 
 
/
 
 
 
 embryos (Fig. 3 E). En-
zymatic desialylation of tissue sections did not enhance
binding of anti-Tn to 
 
T-syn
 
 
 
/
 
 
 
 embryos (unpublished data).
Furthermore, anti–sialyl-Tn did not stain 
 
T-syn
 
 
 
/
 
 
 
 embryos
(Fig. 3 F), although it did stain fixed Jurkat cells, which are
known to express the sialyl-Tn antigen (unpublished data).
Anti-T did not stain 
 
T-syn
 
 
 
/
 
 
 
 embryos, and anti-Tn did not
stain 
 
T-syn
 
 
 
/
 
  embryos (Fig. 3 B). These results corroborate
the lectin blotting data, and they demonstrate that sialic acid
modifies the T antigen on T-syn
 /  embryos but does not
appreciably modify the Tn antigen on T-syn
 /  embryos.
Epithelial cells in some adult tissues transfer GlcNAc from
UDP-GlcNAc to the Tn antigen to form the core 3 disac-
charide, which is also the precursor for core 4 O-glycans
(Van den Steen et al., 1998; Brockhausen, 1999; Fig. 1 A).
However, Fig. 3 E demonstrates that T-syn
 /  embryos do
not synthesize sufficient core 3 O-glycans to modify all the
exposed Tn antigen. Interestingly, Maackia amurensis he-
magglutinin, a lectin that recognizes  2-3–linked sialic acid,
stained T-syn
 /  embryos much more strongly than T-syn
 / 
embryos (Fig. 4, A–D). This suggests that most  2-3–
linked sialic acid is on core 1–derived O-glycans at this stage
of development or that the lectin preferentially binds to  2-
Figure 1. Generation of T-synthase–deficient mice. (A) Schematic 
of biosynthesis of the four common O-glycan core structures. The 
cores can be further extended and modified as indicated by additional 
arrows. The biosynthetic step that T-synthase catalyzes is shown. 
(B) Wild-type (Wt) T-syn allele showing the site of PCR 1 used for 
genotyping. (C) Targeted T-syn allele in embryonic stem cells after 
homologous recombination with the targeting vector. Exons 1 and 2 
and a neomycin cassette (Neo) are flanked by three loxP sites. 
(D) Deletion of loxP-flanked exons 1 and 2 and Neo in embryonic 
stem cells after in vitro Cre-mediated recombination. The site of 
PCR 2 used for genotyping is indicated. (E) PCR genotyping of DNA 
from mouse embryos. PCR 1 amplifies a 430-bp fragment from 
the Wt allele, and PCR 2 amplifies an 810-bp fragment from the 
Cre-deleted allele. (F) T-synthase and  1-4-galactosyltransferase 
( 1-4GalT) activities in E12 tissue extracts. The data represent the 
mean   SD of three independent measurements.Angiogenesis requires core 1 O-glycosylation | Xia et al. 453
Figure 2. Targeted disruption of T-syn causes fatal 
embryonic hemorrhage in mice. (A) Comparison of 
T-syn
 /  and T-syn
 /  embryos at different develop-
mental stages. Blood is visible in the hearts of the older 
T-syn
 /  embryos. Arrowheads indicate hemorrhage 
in the brain parenchyma and ventricles, spinal cord, 
and spinal canal of T-syn
 /  embryos. Less blood is 
detected in T-syn
 /  hearts because of anemia. The 
E14 T-syn
 /  embryo is dead and appears pale 
because blood circulation has ceased. (B) Sagittal 
section of the E12 T-syn
 /  embryo. The red and black 
boxes indicate hemorrhagic lesions, which are shown 
at higher magnification in C and D. Bleeding is visible 
in both the brain parenchyma and ventricles. 
Arrows indicate erythrocytes, which are nucleated 
at this stage of development.
Figure 3. Disruption of T-syn eliminates T antigen 
expression and exposes the Tn antigen in murine 
embryos. (A) Blots of E12 tissue extracts probed with 
PNA, which recognizes nonsialylated core 1 O-glycans, 
and with HPA, which recognizes the nonsialylated Tn 
antigen. The extracts were incubated with or without 
sialidase before electrophoresis and blotting. The asterisk 
indicates the binding of PNA to the added sialidase. 
The blots are representative of three experiments. 
(B–F) Immunohistochemical staining of E12 tissue 
sections with mAbs to the T antigen, Tn antigen, or 
sialyl-Tn (sTn) antigen. The sections in D were pre-
treated with sialidase. Brown reaction product marks 
sites of antibody binding. Arrows, endothelial cells; 
arrowheads, epithelial cells; and asterisks, hemato-
poietic cells. Bars, 50  m.454 The Journal of Cell Biology | Volume 164, Number 3, 2004
3–sialylated O-glycans. In contrast, Sambucus nigra agglu-
tinin, which recognizes  2-6–linked sialic acid, stained
T-syn
 /  and T-syn
 /  embryos equivalently (Fig. 4, E–H).
Because T-syn
 /  embryos add little or no  2-6–linked sialic
acid to form the sialyl-Tn antigen, most of the  2-6–linked
sialic acid may be on N-glycans.
T-syn
 /  embryos have normal plasma-based 
blood coagulation
Hemorrhage may result from defects in the plasma or cellu-
lar components of the hemostatic system or in the vascula-
ture. Some murine embryos lacking any one of several differ-
ent coagulation proteins suffer fatal hemorrhage, but unlike
T-syn
 /  embryos, other embryos lacking the same protein
escape bleeding and survive until birth (Bugge et al., 1996;
Carmeliet et al., 1996; Connolly et al., 1996; Cui et al.,
1996; Sun et al., 1998; Xue et al., 1998). Coagulation factors
V and VIII are modified with O-glycans of unknown func-
tion (Kaufman, 1998). Plasma from T-syn
 /  and T-syn
 / 
embryos clotted at similar rates as assessed by modified pro-
thrombin times and activated partial thromboplastin times
(Fig. 5, A and B). Furthermore, plasma from embryos of
both genotypes corrected defective clotting of human plasma
deficient in factor V or factor VIII (Fig. 5 C). These results
argue against a general defect in plasma-based blood coagula-
tion. O-glycosylation of platelet proteins might affect their
hemostatic functions, but mice lacking platelets develop nor-
mally (Shivdasani et al., 1995). Because cell surface proteins
rich in negatively charged, sialylated O-glycans have been
suggested to reduce cell–cell interactions (Fukuda, 2002), we
considered whether reduced sialylation of T-syn
 /  blood
cells might cause them to agglutinate and occlude ves-
sels, leading to secondary hemorrhage. However, Wright-
Giemsa–stained smears of T-syn
 /  blood showed no aggluti-
nation. Intravital microscopy also revealed normal blood flow
Figure 4. Expression of  2-3–linked and  2-6–linked sialic acid in T-syn
 /  and T-syn
 /  embryos. (A–H) Sections of the indicated tissues 
were pretreated with or without sialidase and stained with Maackia amurensis hemagglutinin (MAH), which recognizes  2-3–linked sialic 
acid, or with Sambucus nigra (SNA), which recognizes  2-6–linked sialic acid. Note that MAH binds much less to T-syn
 /  embryos than to 
T-syn
 /  embryos. Pretreatment of the sections with sialidase eliminated binding of MAH and SNA, confirming their specificity. Bars, 50  m.
Figure 5. Plasma-based blood coagulation is equivalent in T-syn
 /  
and T-syn
 /  embryos. Clotting of individual plasma samples from 
eight E12 T-syn
 /  embryos and six E12 T-syn
 /  embryos (mean   SD, 
P   0.05) was measured by the kinetic activated partial thrombo-
plastin time (A) and the kinetic prothrombin time (B). (C) The 
activated partial thromboplastin time of human plasma deficient in 
factor V or factor VIII was measured with or without supplementation 
with normal human plasma or with pooled plasma from T-syn
 /  
or T-syn
 /  embryos. The data represent the mean   SD of three 
independent experiments.Angiogenesis requires core 1 O-glycosylation | Xia et al. 455
in large vessels of T-syn
 /  yolk sacs, except that fewer cells
circulated because of anemia (Videos 1 and 2, available at
http://www.jcb.org/cgi/content/full/jcb.200311112/DC1).
T-syn
 /  embryos develop a chaotic 
microvascular network
The earliest blood vessels arise by vasculogenesis, which is
the differentiation of precursor cells into endothelial cells
that form a primitive capillary plexus. New capillaries then
develop by angiogenesis, in which endothelial cells migrate
into previously avascular areas. These vessels mature as en-
dothelial cells recruit pericytes, deposit extracellular matrix,
and develop an organized branched network (Carmeliet,
2003; Jain, 2003). Mice lacking proteins that affect the re-
cruitment or critical functions of endothelial cells or peri-
cytes exhibit defective vasculogenesis or angiogenesis, and
they frequently die from embryonic or perinatal hemor-
rhage (Liu et al., 2000; McCarty et al., 2002; Zhu et al.,
2002; Carmeliet, 2003; Jain, 2003). Using confocal micros-
copy, we integrated optical slices of thick tissue sections to
visualize the microvascular architectures of T-syn
 /  and
T-syn
 /  E12 embryos. In brains of T-syn
 /  embryos, en-
dothelial cells marked by anti-CD31 antibodies were observed
in the perineural plexus, which arises by vasculogenesis (Fig.
6 A). Endothelial cells in parenchymal vessels, which de-
velop exclusively by angiogenesis, formed capillaries of rela-
tively uniform diameters with orderly branching patterns.
Pericytes marked by antibodies to the proteoglycan NG2
(Ozerdem et al., 2001) were associated with endothelial
cells in both the perineural plexus and the brain paren-
chyma (Fig. 6, C and E). In brains of T-syn
 /  embryos, en-
dothelial cells and pericytes developed an apparently normal
perineural plexus (Fig. 6, B, D, and F). However, endothe-
lial cells in the brain parenchyma formed a chaotic mi-
crovasculature with irregular capillary diameters and disor-
dered branching, indicating dysregulated angiogenesis (Fig.
6 B). Antibodies to NG2 stained the T-syn
 /  brain vessel
network, arguing that the vascular defect did not result from
failure to recruit pericytes (Fig. 6, D and F). Laminin, a
basement membrane component, was detected in the mi-
crovasculature of both T-syn
 /  and T-syn
 /  brains (Fig. 6,
G and H). Confocal microscopy did not reveal obvious de-
fects in the microvasculature of other T-syn
 /  embryonic
organs, and the architecture of large vessels in the yolk sac
and other organs was grossly normal (Fig. 6, I and J). How-
ever, whole mounts demonstrated more capillary branching
and more irregular vessel diameters in T-syn
 /  yolk sacs
than in T-syn
 /  yolk sacs (Fig. 6, K and L). Immunoblots
of T-syn
 /  and T-syn
 /  embryonic lysates showed no ob-
vious differences in the levels of vascular endothelial growth
factor, angiopoietin-1, Tie2, or platelet-derived growth fac-
tor B (unpublished data). This finding suggests that defec-
tive angiogenesis in T-syn
 /  embryos does not result from a
secondary increase or decrease in these known regulators of
angiogenesis (Carmeliet, 2003; Jain, 2003).
T-syn
 /  embryos have defective association of 
endothelial cells with pericytes and
extracellular matrix
We used electron microscopy to better characterize the
structures of T-syn
 /  and T-syn
 /  brain capillaries. The
endothelial cells of T-syn
 /  capillaries were relatively uni-
form in size and were intimately associated with pericytes
(Fig. 7, A and E). In sharp contrast, most endothelial cells of
T-syn
 /  capillaries exhibited distorted shapes with irregular
or dilated capillary lumens and with focal cytoplasmic thin-
Figure 6. T-syn
 /  embryos develop a 
chaotic microvascular network. (A–H) 
Visualization of microvessels in E12 
hindbrains using maximal intensity 
projections of z-stacked confocal images. 
Endothelial cells were stained with anti-
bodies to CD31 (green); pericytes were 
stained with antibodies to the proteoglycan 
NG2 (red); and basement membrane 
was stained with antibodies to laminin 
(red). T-syn
 /  embryos form a network 
of capillaries with uniform diameters 
and a regular branching pattern (A, C, E, 
and G), whereas T-syn
 /  embryos form 
capillaries with heterogeneous diameters 
and excessive, irregular branches (B, D, 
F, and H). Insets in E and F are thin (5  m) 
optical slices of representative vessels 
enlarged 2.5-fold, which illustrate the 
abluminal relationship of the NG2-
positive pericytes to the CD31-positive 
endothelial cells. P, perineural vascular 
plexus; V, ventricle. (I and J) The archi-
tecture of large vessels (arrowheads) is 
similar in T-syn
 /  and T-syn
 /  E12 yolk 
sacs, except that less blood fills the 
T-syn
 /  vessels because of anemia. (K and L) Staining of whole mounts of E12 yolk sacs with antibodies to CD31. More capillary branching 
and irregular vessel diameters are present in the T-syn
 /  yolk sac. Arrowheads indicate narrowed capillaries at branch points, which sug-
gests incomplete vascular pruning. Bars, 50  m, unless otherwise noted.456 The Journal of Cell Biology | Volume 164, Number 3, 2004
ning (Fig. 7, B–E). Mature interendothelial cell junctions
were present, but pericytes typically lacked their normal
close apposition to the endothelial cells. Many endothelial
cells and pericytes were also surrounded by large spaces, in-
dicating unstable interactions with the extracellular matrix
or neighboring cells. The morphological abnormalities pre-
ceded hemorrhage and tended to be more severe near bleed-
ing lesions. This implies that the structural defects are di-
rectly responsible for hemorrhage.
Discussion
Our results reveal a critical and unexpected contribution of
core 1–derived O-glycans to angiogenesis. Blood vessels in
the developing brain parenchyma arise exclusively by angio-
genesis (Carmeliet, 2003; Jain, 2003), which probably ex-
plains why vascular defects in T-syn
 /  embryos were most
abundant in this tissue. The separation of endothelial cells
from supporting pericytes and extracellular matrix is a likely
mechanism for the capillary fragility in T-syn
 /  embryos.
The structural abnormalities might result from altered gly-
cosylation of an adhesion molecule on cell surfaces or in the
extracellular matrix, or they might develop through an
O-glycosylation–dependent change in cell signaling. Endo-
thelial cells and pericytes engage in bidirectional signaling
that promotes vascular integrity and remodeling (Carmeliet,
2003; Jain, 2003). However, the vascular defects in T-syn
 / 
embryos do not appear to be due solely to defective support
from pericytes. Mice lacking platelet-derived growth factor
B or its receptor fail to recruit pericytes to developing brain
vessels (Lindahl et al., 1997), yet they do not bleed until the
late embryonic or perinatal period (Leveen et al., 1994; Sori-
ano, 1994). In contrast, T-syn
 /  embryos invariably die of
hemorrhage by E14. This implies that one or more endothe-
lial cell proteins require core 1–derived O-glycans to sup-
port angiogenesis. Targeted deletion of T-syn in endothelial
cells will help address this possibility. The chaotic vascular
branching in T-syn
 /  embryonic brains indicates that the
vessels fail to remodel into a hierarchical network.
The specific functions of core 1–derived O-glycans in an-
giogenesis remain to be determined. A core 1 O-glycan or
one of its modified forms might serve as an essential ligand
for an uncharacterized lectin. Myelin-associated glycopro-
tein (MAG), a member of the siglec family of lectins that
recognize sialic acid–containing glycans (Crocker, 2002),
binds exceptionally well to the sialyl-T antigen in vitro (Blixt
et al., 2003). This raises the possibility that MAG, which is
secreted from oligodendrocytes, might regulate angiogenesis
by binding to the sialyl-T determinant on endothelial cell
glycoproteins. However, MAG-deficient mice develop nor-
mally and do not have obvious defects in angiogenesis (Li et
al., 1994). Therefore, defective interactions of MAG with
sialylated core 1 O-glycans cannot be the sole explanation
for the disordered angiogenesis in brains of T-syn
 /  em-
bryos. A core 1 O-glycan or one of its derivatives might also
modulate the conformation of a protein that affects an-
giogenesis. Mucinlike domains have extended structures
that are largely mediated by interactions of peptide-linked
GalNAc residues with adjacent amino acids (Rose et al.,
1984; Gerken et al., 1989; Shogren et al., 1989; Merry et al.,
2003). The expression of the Tn antigen in T-syn
 /  em-
bryos suggests that these GalNAc–peptide interactions re-
main intact, which should prevent major structural changes
in proteins that normally have many core 1–derived O-gly-
cans. Defective core 1 O-glycosylation might still cause sub-
tle, but functionally important, alterations in protein con-
formation or increase access to proteolytic attack. It is also
possible that the exposed Tn antigen binds to an unknown
lectin that interferes with angiogenesis.
Little is known about the synthesis of GalNAc-anchored
O-glycans during development. A large family of N-acetyl-
galactosaminyltransferases transfer GalNAc from UDP-Gal-
NAc to serine or threonine residues. During murine devel-
opment, mRNAs encoding many of these enzymes are
expressed in discrete patterns in multiple tissues, but their
functions have not been addressed (Kingsley et al., 2000).
Our immunohistochemical data indicate that core 1 O-gly-
cans are expressed primarily in endothelial, hematopoietic,
and epithelial cells during development. This suggests that
these cells express the majority of the Ser/Thr-rich proteins
that are O-glycosylated to become mucins. Other cells
might express fewer or less clustered core 1 O-glycans that
were not detected by immunohistochemistry. Most of the
simple core 1 O-glycans (T antigen) were  2-3 sialylated to
Figure 7. T-syn
 /  embryos have defective capillary structures. 
(A–D) Electron micrographs of sections from E12 brains. (A) A T-syn
 /  
capillary has a uniform lumen and a pericyte that is intimately 
associated with the endothelial cell. (B–D) T-syn
 /  capillaries have 
distended or distorted lumens with attenuated endothelial cell 
processes. The upper pericyte in C is in close contact with an 
endothelial cell, but other pericytes are partially or completely 
separated from the endothelial cells. Large empty spaces (asterisks) 
surround the capillaries. Both T-syn
 /  and T-syn
 /  capillaries have 
normal interendothelial cell junctions (arrowheads). Ec, endothelial 
cell; Pc, pericyte. (E) Sections of capillaries were scored for pericytes 
closely attached to endothelial cells and for distortions in endothelial 
cell shape. Bars, 2  m.Angiogenesis requires core 1 O-glycosylation | Xia et al. 457
form the sialyl-T antigen. Other core 1 O-glycans might be
extended or branched to form more complex structures. The
large reduction in binding of Maackia amurensis hemaggluti-
nin to T-syn
 /  embryonic tissues suggests that core 1–derived
O-glycans display most of the  2-3–linked sialic acid. Al-
though this decrease in sialylation could conceivably reduce
charge-based repulsion among cells, we observed no evi-
dence of abnormal cell agglutination in the circulation or in
other tissues. This may be due to the continued expression
of  2-6–linked sialic acid, which appeared to be present pri-
marily on N-glycans. The Tn antigen exposed on endothe-
lial, hematopoietic, and epithelial cells of T-syn
 /  embryos
was not  2-6 sialylated to form the sialyl-Tn antigen, as may
occur on some malignant cells (Brockhausen et al., 1998).
Our data provide the first demonstration that normal de-
velopment requires an O-glycosylation pathway that begins
by attachment of GalNAc to serines or threonines. A much
less common O-glycosylation pathway begins with direct at-
tachment of fucose to serines or threonines on epidermal
growth factor–like domains (Shao and Haltiwanger, 2003).
Mice lacking the protein O-fucosyltransferase die in midges-
tation from multiple morphogenetic defects, reflecting the
critical contribution of O-fucosylation to the Notch protein
signaling pathway (Shi and Stanley, 2003). In contrast, de-
fective angiogenesis leading to bleeding is the only detectable
abnormality in T-syn
 /  embryos. The relatively restricted
expression of detectable core 1 O-glycans in endothelial, he-
matopoietic, and epithelial cells may explain why T-syn
 / 
embryos do not exhibit multiple developmental defects that
cause earlier death. Core 1 O-glycans or their derivatives
might contribute to physiological or pathological angiogene-
sis in adults. The expression of core 1 O-glycans in epithelial
cells deserves further exploration, and other cells might ex-
press core 1 or core 2 O-glycans late in development or
during adult life. Inducible or cell type–specific deletion of
T-syn may reveal other important functions for core 1
O-glycosylation of proteins.
Materials and methods
Generation of T-syn
 /  mice
All animal experiments were performed in compliance with relevant laws
and were approved by the Institutional Animal Care and Use Committee of
the Oklahoma Medical Research Foundation. A bacterial artificial chro-
mosome containing the murine T-syn gene was identified by screening a
murine embryonic stem cell library (Incyte Genomics) by PCR. Southern
blot analysis showed that murine T-syn, like the corresponding human
gene (Ju et al., 2002a), has three exons. Exon 1 is 0.3 kb and encodes the
ATG translational start site, cytoplasmic domain, transmembrane domain,
and stem region of T-synthase. Exon 2 is 0.6 kb and encodes the majority
of the catalytic domain. Exon 3 is 0.3 kb and encodes the rest of the cata-
lytic domain as well as the 3 -untranslated region. We engineered a target-
ing vector with three loxP sites in the T-syn allele, which flanked exons 1
and 2 and an inserted Neo cassette. The targeting vector was electropo-
rated into CJ7 embryonic stem cells that were derived from a 129/SvlmJ
mouse (a gift from T. Sato, University of Texas Southwestern Medical
School, Dallas, TX, with permission from T. Gridley, The Jackson Labora-
tory, Bar Harbor, ME). Embryonic stem cell clones with correct homolo-
gous recombination were screened by PCR and confirmed by Southern
blots. Cells from one clone were transiently transfected with an expression
vector encoding Cre recombinase (a gift from B. Sauer, Stowers Institute for
Medical Research, Kansas City, MO) to delete exons 1 and 2 and the Neo
cassette. Cells confirmed to have a normal karyotype were microinjected
into C57BL/6J blastocysts, which were then implanted into pseudopreg-
nant mice. Chimeras among the offspring were bred with C57BL/6J mice.
Genotypes of mice were determined by PCR of DNA from tail biopsies or
from portions of embryos or yolk sacs. The wild-type allele was identified us-
ing PCR 1 (primers 5 -TGGGTTATGACAAGTCCTC-3  and 5 -TCATGTA-
TCCCTGCTTCAC-3 ). The mutant allele was detected by PCR 2 (primers
5 -GATAAATGTCTTACAGAAGG-3  and 5 -AATACTGTCCTGGGCTAT-
ACTACAGTG-3 ). Comparative studies of T-syn
 / , T-syn
 / , and T-syn
 / 
embryos were always performed with embryos from the same litter.
Glycosyltransferase assays
T-synthase activity from murine embryo extracts was measured using
GalNAc 1-O-phenyl (Sigma-Aldrich) as an acceptor (Ju et al., 2002b).
UDP-[
3H]Gal (40–60 Ci/mmol) was obtained from American Radiolabeled
Chemicals, Inc. Activity of a control enzyme,  1-4-galactosyltransferase,
was measured using GlcNAc-S-pNp (American Radiolabeled Chemicals,
Inc.) as the acceptor in a 50- l reaction containing 50 mM Tris-HCl, pH
7.0, 2 mM GlcNAc-S-pNp, 200  M UDP-[
3H]Gal (60,000–90,000 cpm),
20 mM MnCl2, 0.1% Triton X-100, and 100  g of protein from embryo ex-
tracts. The reactions were incubated at 37 C for 1 h and stopped by adding
950  l of cold H2O. The products were separated from UDP-[
3H]Gal by
Sep-Pak (C18; Waters Corporation) column chromatography and were
quantified (Ju et al., 2002b).
Lectin blots and immunoblots
Embryo extracts (40  g of protein) with or without prior desialylation were
resolved by SDS-PAGE under reducing conditions and transferred to a ni-
trocellulose membrane (Bio-Rad Laboratories). For desialylation, 200  g of
embryonic protein in a 40- l reaction volume was incubated with 20 mU
sialidase from Arthrobacter ureafaciens (Roche) overnight at 37 C. The
membrane was blocked with 5% nonfat dry milk and incubated with 2  g/
ml HRP-conjugated PNA or 0.25  g/ml HPA (EY Laboratories) in TBS at RT
for 1 h. Lectin binding was detected with chemiluminescent substrate
(HighSignal West Pico; Pierce Chemical Co.). Alternatively, the membrane
was probed with rabbit antibodies to angiopoetin 1, Tie2, VEGF, PDGF B,
and actin (Santa Cruz Biotechnology, Inc.). Binding was detected with
HRP-conjugated goat anti–rabbit IgG (Pierce Chemical Co.) using ECL
(Amersham Biosciences).
Blood coagulation assays
2–3  l of blood from E12 embryos was harvested into 40  l TBS contain-
ing 0.19% sodium citrate. Plasma was obtained after centrifugation. Ki-
netic coagulation assays in 96-well microtiter plates were conducted using
minor modifications of protocols described for zebrafish (Sheehan et al.,
2001). In brief, 10  l of plasma from each embryo, adjusted to the same
protein concentration, was added to a well containing 3 mg/ml of purified
human fibrinogen (Calbiochem) in a total volume of 50  l. For the kinetic
activated partial thromboplastin time, 15  l of partial thromboplastin re-
agent (Dade Actin; Dade Behring, Inc.) and 8 mM CaCl2 were added. For
the kinetic prothrombin time, 30  l Thromboplastina C Plus (Dade
Behring, Inc.) was added. Clot formation at RT was monitored with a ki-
netic microplate reader (Molecular Devices) set at 405 nm. Embryo plasma
was replaced with TBS as a negative control.
For the coagulation correction assay, 50  l of pooled murine embryo
plasma was mixed with 100  l of human plasma deficient in factor V or
factor VIII (Fisher Scientific). Coagulation triggered by the addition of par-
tial thromboplastin reagent and CaCl2 was measured on a coagulation ana-
lyzer (model Start 4; Diagnostica Stago). Pooled normal human plasma di-
luted to the same protein concentration as the embryo plasma was used as
a positive control.
Microscopy
Embryos were photographed at autopsy. For routine histological analysis,
embryos were fixed in 10% neutral pH formalin overnight at 4 C, embed-
ded in paraffin, sectioned at 4- m thickness, and stained with hematox-
ylin-eosin. For immunohistochemistry, deparaffinized sections were incu-
bated with or without 0.5 U/ml sialidase from Arthrobacter ureafaciens at
37 C for 3 h. Sections were incubated with mAbs against the T, Tn, or sia-
lyl-Tn antigens (Mandel et al., 1991; mouse IgG or IgM, gifts from U. Man-
del and H. Clausen, School of Dentistry, University of Copenhagen,
Copenhagen, Denmark) or with isotype-matched control mouse IgG or
IgM. Bound antibodies were detected with HRP-conjugated goat anti–
mouse IgG/IgM (DakoCytomation). Alternatively, sections were incubated
with peroxidase-conjugated Maackia amurensis or Sambucus nigra he-
magglutinin (EY Laboratories). Immunohistochemical staining was devel-
oped with a DAB peroxidase substrate kit (Vector Laboratories).
For confocal microscopy, embryos were fixed in 4% PFA in 0.1 M PBS
at RT for 90–120 min, washed, cryoprotected with 15% sucrose in PBS at458 The Journal of Cell Biology | Volume 164, Number 3, 2004
4 C overnight, mounted in Tissue-Tek O.C.T. compound, and snap-frozen
in liquid nitrogen–cooled isopentane. 100- m-thick cryosections were
quenched with 0.1 M glycine in PBS, washed twice, and blocked with 3%
BSA in PBS containing 0.01% saponin. Sections were incubated with rat
anti–murine CD31 mAb (1:10 dilution; BD Biosciences) and rabbit anti-
NG2 antibody (1:200 dilution; Chemicon) in 0.3% BSA in PBS with 0.01%
saponin or with rabbit antilaminin antibody (1:500 dilution; DakoCytoma-
tion) for 1 h at RT. Thereafter, the sections were washed in PBS containing
0.01% saponin and incubated with Cy3-conjugated goat anti–rabbit anti-
body (1:100 dilution; Vector Laboratories) and biotinylated goat anti–rat
IgG absorbed to remove anti–murine IgG (1:100 dilution; Vector Laborato-
ries), followed by streptavidin conjugated to FITC (1:100 dilution; Vector
Laboratories). The sections were mounted with Vectashield (Vector Labo-
ratories) and analyzed by three-dimensional confocal laser scanning mi-
croscopy using a scanning head (model C1; Nikon) mounted on an
inverted microscope (model ECLIPSE 2000U; Plan Apochromats dry ob-
jective lens, 20 , NA 0.75; Nikon). Z-stack images were collected at 1- m
steps with sequential laser excitation to eliminate bleedthrough and with
confocal parameters selected to minimize the thickness of the calculated
optical section. Volume images from the confocal data sets were pro-
cessed with IMARIS software (Bitplane AG) for three-dimensional views of
the detailed vascular morphology. Images are presented as maximum in-
tensity projections of the z stacks.
For whole-mount immunofluorescence, yolk sacs were fixed in 4% PFA
in 0.1 M PBS at RT for 60 min and incubated sequentially with rat anti–
mouse CD31 mAb, biotinylated goat anti–rat IgG, and streptavidin conju-
gated to FITC. The yolk sacs were mounted on slides and visualized with a
Micro and Macro instrument (model ECLIPSE E800M; Nikon).
For transmission electron microscopy, embryos were fixed with 3% PFA
and 2% glutaraldehyde in 0.1 M cacodylate, pH 7.2, for 2 h, postfixed in
2% osmium tetroxide in 0.1 M cacodylate, dehydrated in acetone series,
and embedded in EMbed 812 epoxy resin (Electron Microscopy Sciences,
Inc.). Thin sections stained with uranyl acetate and lead citrate were exam-
ined with an electron microscope (model JEM-1200EX; Jeol).
Intravital microscopy of embryos was performed using procedures de-
scribed previously for adult mice (Xia et al., 2002).
Online supplemental material
Video microscopy of yolk sac blood vessels from living E12 T-syn
 /  em-
bryos (Video 1, wild type) and T-syn
 /  embryos (Video 2, T-syn deficient).
Blood flow is normal in both yolk sacs, except that fewer blood cells are
seen in the T-syn
 /  vessels because of anemia. Online supplemental mate-
rial is available at http://www.jcb.org/cgi/content/full/jcb.200311112/DC1.
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